We performed genetic and phenic analyses to evaluate nucleotide and amino-acid sequences of the amino-terminus of the E1 protein of HCV genotype 1b (extracted from databank) and 4a (characterised in this study). The non-synonymous (ka) mutation analysis demonstrated that the genome of genotype 1b was not saturated by variations, with a rate of transition/transversion (s/v) of 1.5, which is similar to the expected ratio (i.e., 2.0). The s/v ratio in genotype 4a isolates was lower (0.98), indicating saturation due long-term variability. Moreover, the genotype 1b sequences showed a higher number of ka mutations (s+v) (mean of 2.8 per sequence) than genotype 4a (mean of 1.5). The introduction of ka mutations resulted in a higher degree of amino...
A great deal of information on the molecular heterogeneity of hepatitis C virus (HCV) has been achie...
A number of different genotypes of the Hepatitis C virus have been reported in New Zealand (Cooper e...
Treatment with pan-genotypic direct-acting antivirals, targeting different viral proteins, is the be...
We performed genetic and phenic analyses to evaluate nucleotide and amino-acid sequences of the amin...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus (HCV) is a major cause of liver disease and has been estimated to infect approxima...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus (HCV) is a major cause of hepatitis and hepatocellular carcinoma (HCC) world-wide....
Interactions between the host immune system and the viral variants determine persistence of hepatiti...
Hepatitis C virus (HCV) infection affects about 3 % of the human population. Phylogenetic analyses h...
Infection with hepatitis C virus (HCV) is one of the leading causes of chronic hepatitis, liver cirr...
Despite significant progress in hepatitis C (HCV) treatment, global viral eradication remains a chal...
Sequence variation among different hepatitis C virus (HCV) isolates has adaptive significance and re...
A great deal of information on the molecular heterogeneity of hepatitis C virus (HCV) has been achie...
A number of different genotypes of the Hepatitis C virus have been reported in New Zealand (Cooper e...
Treatment with pan-genotypic direct-acting antivirals, targeting different viral proteins, is the be...
We performed genetic and phenic analyses to evaluate nucleotide and amino-acid sequences of the amin...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus (HCV) is a major cause of liver disease and has been estimated to infect approxima...
Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often ass...
Hepatitis C virus (HCV) is a major cause of hepatitis and hepatocellular carcinoma (HCC) world-wide....
Interactions between the host immune system and the viral variants determine persistence of hepatiti...
Hepatitis C virus (HCV) infection affects about 3 % of the human population. Phylogenetic analyses h...
Infection with hepatitis C virus (HCV) is one of the leading causes of chronic hepatitis, liver cirr...
Despite significant progress in hepatitis C (HCV) treatment, global viral eradication remains a chal...
Sequence variation among different hepatitis C virus (HCV) isolates has adaptive significance and re...
A great deal of information on the molecular heterogeneity of hepatitis C virus (HCV) has been achie...
A number of different genotypes of the Hepatitis C virus have been reported in New Zealand (Cooper e...
Treatment with pan-genotypic direct-acting antivirals, targeting different viral proteins, is the be...